INSTITUTION'S PROFILE
Department of Oncology, Novartis Pharmaceuticals S.A.S., Rueil-Malmaison, France.
Publications (1)
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study.
Journal: PloS one
Publication date: 2017
Journal: PloS one
Publication Year: 2017